Tata India Pharma & HealthCare Fund
Sectoral-PharmaVery HighOPEN-ENDED
- NAV as on 6 Nov 2026
- ₹32.88+0.68%1 day
- Return since launch
- 11.5%
- 52-week range
- ₹27.91 — ₹34.00
- AUM
- ₹1,511 Cr
Tata India Pharma & HealthCare Fund is a Sectoral-Pharma equity fund from Tata Mutual Fund with ₹1,511 Cr under management, launched in 2015. Over three years it has returned 9.5% a year, against 21.0% for its category. The expense ratio is 2.41% and the SEBI riskometer reading is Very High.
Performance
Tata India Pharma & HealthCare Fund NAV and returns
Growth of the fund against its category average over the period you pick.
Over 1Y this fund returned +7.2% against +16.7% for its category.
Performance
Returns
How the fund has done against its category and its benchmark.
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1Y | 11.9% | −6.3 pts | 18.1% | 23.9% |
| 2Y | 8.1% | −8.4 pts | 16.5% | 15.0% |
| 3Y | 9.5% | −11.5 pts | 21.0% | 14.3% |
| 5Y | 15.3% | +0.2 pts | 15.0% | 17.5% |
| 7Y | 16.2% | −2.1 pts | 18.3% | 17.3% |
| 10Y | 16.5% | +2.1 pts | 14.3% | 16.7% |
| Period | Fund | vs category | Category | Benchmark |
|---|---|---|---|---|
| 1M | 2.9% | −1.0 pts | 3.9% | 6.4% |
| 3M | -2.8% | −4.0 pts | 1.2% | 0.9% |
| 6M | 5.3% | −6.8 pts | 12.1% | 11.3% |
| 1Y | 7.2% | −10.9 pts | 18.1% | 16.3% |
| 2Y | 3.7% | −4.9 pts | 8.6% | 7.4% |
| 3Y | 17.4% | −3.6 pts | 21.0% | 19.3% |
| 5Y | 13.7% | −1.3 pts | 15.0% | 14.1% |
| 7Y | 20.1% | −1.7 pts | 21.8% | 20.8% |
| 10Y | 13.7% | −0.7 pts | 14.3% | 13.2% |
Since launch (4 Dec 2015): 11.5%
Calendar-year returns
Category average64.4%
19.1%
-8.0%
36.6%
40.0%
-4.9%
Show as a table
| Period | Fund | vs category | Category |
|---|---|---|---|
| 2025 | -4.9% | −2.9 pts | -2.0% |
| 2024 | 40.0% | −0.9 pts | 40.9% |
| 2023 | 36.6% | +0.3 pts | 36.2% |
| 2022 | -8.0% | +0.2 pts | -8.3% |
| 2021 | 19.1% | −2.6 pts | 21.7% |
| 2020 | 64.4% | −4.4 pts | 68.8% |
Returns over one year are annualised. Shorter periods are absolute.
Costs & terms
Costs and terms
What the fund charges each year, and the rules around putting money in and taking it out.
Costs
2.41%
Expense ratio as on 6 Nov 2026
Charged yearly and already deducted from the NAV.
- Base expense
- 1.80%
- Brokerage
- 0.11%
- Transaction charges
- 0.01%
- Statutory levies
- 0.49%
- Exit load
- Exit load of 0.25% if redeemed within 30 days.
- Lock-in
- None
Terms
- Min SIP
- ₹3,000
- Min lumpsum
- ₹5,000
- Plan
- GROWTH
- Fund type
- OPEN-ENDED
- Benchmark
- BSE Healthcare TRI
- Short-term capital gains
- Returns taxed at 20% if you redeem before 1 year
- Long-term capital gains
- After 1 year, returns above ₹1.25 lakh in a financial year are taxed at 12.5%
Risk
Risk
What the riskometer means for this fund, and how its ratios sit against the category.
Very High
Your principal is treated as being at very high risk — typically small cap, sectoral and thematic equity schemes.
| Ratio | Fund | Category avg | Read as |
|---|---|---|---|
| Alpha | -4.64 | 1.49 | Return earned above what the benchmark alone would have given. Higher is better. |
| Beta | 1.00 | 0.94 | How hard the fund moves when the market moves. Under 1 is steadier than the market. |
| Sharpe | 0.74 | 1.10 | Return earned for each unit of total risk taken. Higher is better. |
| Sortino | 1.14 | 1.81 | Return earned for each unit of downside risk. Higher is better. |
| Std. deviation | 16.53 | 15.62 | How widely monthly returns have varied around their own average. Lower is steadier. |
| Average of 5 category peers | |||
Portfolio
Tata India Pharma & HealthCare Fund portfolio
Portfolio as of 30 Sep 2026
Asset allocation
- Equity99.7%
- Other0.3%
Market cap split
- Large26.1%
- Mid34.6%
- Small39.4%
- P/E
- 40.30
- P/B
- 5.52
Top holdings
| Holding | Sector | Weight | Value | 3M chg | 6M chg | 1Y chg |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Healthcare | 7.99% | ₹121 Cr | +8.51% | +10.34% | +10.03% |
| Abbott India Ltd. | Healthcare | 5.94% | ₹89.75 Cr | +4.97% | +5.89% | +2.90% |
| Healthcare Global Enterprises Ltd. | Healthcare | 5.92% | ₹89.52 Cr | +5.52% | +5.39% | +4.68% |
| Divi's Laboratories Ltd. | Healthcare | 5.68% | ₹85.82 Cr | +5.12% | +5.83% | +3.86% |
| Dr. Reddy's Laboratories Ltd. | Healthcare | 4.65% | ₹70.32 Cr | +4.26% | +3.45% | +1.71% |
| Apollo Hospitals Enterprise Ltd. | Healthcare | 4.36% | ₹65.90 Cr | +4.61% | +4.25% | +5.06% |
| Rainbow Children's Medicare Ltd. | Healthcare | 4.30% | ₹65.07 Cr | +4.42% | +4.23% | +2.82% |
| Cipla Ltd. | Healthcare | 4.22% | ₹63.78 Cr | +4.77% | +5.10% | +4.86% |
| Torrent Pharmaceuticals Ltd. | Healthcare | 3.76% | ₹56.88 Cr | +1.02% | +1.10% | +4.68% |
| Max Healthcare Institute Ltd. | Healthcare | 3.71% | ₹56.09 Cr | +5.68% | +5.14% | +3.95% |
| Lupin Ltd. | Healthcare | 3.14% | ₹47.40 Cr | +2.81% | +3.18% | +4.88% |
| Bayer CropScience Ltd. | Chemicals | 2.96% | ₹44.69 Cr | +3.20% | +3.51% | — |
| Syngene International Ltd. | Healthcare | 2.85% | ₹43.10 Cr | +2.73% | +2.64% | +1.73% |
| Procter & Gamble Health Ltd. | Healthcare | 2.75% | ₹41.50 Cr | +1.79% | +0.70% | — |
| Sai Life Sciences Ltd. | Healthcare | 2.60% | ₹39.34 Cr | +2.53% | +2.58% | +1.08% |
| PI Industries Ltd. | Chemicals | 2.59% | ₹39.16 Cr | — | +0.63% | +2.64% |
| Anthem Biosciences Ltd. | Healthcare | 2.57% | ₹38.89 Cr | — | — | — |
| Pfizer Ltd. | Healthcare | 2.50% | ₹37.85 Cr | +2.50% | — | +0.41% |
| Alkem Laboratories Ltd. | Healthcare | 2.36% | ₹35.66 Cr | +2.64% | +2.45% | +4.46% |
| FDC Ltd. | Healthcare | 2.24% | ₹33.84 Cr | +2.34% | +1.84% | +2.14% |
| Acutaas Chemicals Ltd. | Healthcare | 1.95% | ₹29.44 Cr | — | — | — |
| Fortis Healthcare Ltd. | Healthcare | 1.95% | ₹29.49 Cr | +3.35% | +3.17% | +1.91% |
| Dr. Lal Pathlabs Ltd. | Healthcare | 1.76% | ₹26.67 Cr | +1.64% | +2.69% | +2.94% |
| Aster DM Quality Care Ltd. | Healthcare | 1.67% | ₹25.27 Cr | — | — | +4.63% |
| Ajanta Pharma Ltd. | Healthcare | 1.63% | ₹24.64 Cr | +1.60% | +2.04% | +2.97% |
| Natco Pharma Ltd. | Healthcare | 1.51% | ₹22.77 Cr | — | — | — |
| Sumitomo Chemical India Ltd. | Chemicals | 1.38% | ₹20.79 Cr | +0.97% | +0.39% | — |
| Gillette India Ltd. | Consumer Staples | 1.23% | ₹18.57 Cr | +1.23% | — | — |
| Navin Fluorine International Ltd. | Chemicals | 1.18% | ₹17.79 Cr | — | — | — |
| Ipca Laboratories Ltd. | Healthcare | 0.91% | ₹13.79 Cr | +0.58% | 0.00% | +3.20% |
| Prasol Chemicals Ltd. | Chemicals | 0.88% | ₹13.28 Cr | — | — | — |
| Symbiotec Pharmalab Ltd. | Healthcare | 0.87% | ₹13.21 Cr | — | — | — |
| Mankind Pharma Ltd. | Healthcare | 0.77% | ₹11.58 Cr | +3.85% | +3.57% | +2.33% |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | 0.76% | ₹11.55 Cr | +4.12% | +2.14% | — |
| Biocon Ltd. | Healthcare | 0.69% | ₹10.36 Cr | — | — | — |
| Dr. Agarwal's Health Care Ltd. | Healthcare | 0.68% | ₹10.32 Cr | +0.60% | +0.07% | +2.39% |
| Manipal Health Enterprises Ltd. | Healthcare | 0.59% | ₹8.98 Cr | — | — | — |
| Zim Laboratories Ltd. | Healthcare | 0.58% | ₹8.71 Cr | +0.49% | — | — |
| Sanofi Consumer Healthcare India Ltd. | Healthcare | 0.57% | ₹8.67 Cr | — | — | — |
| Molbio Diagnostics Ltd. | Healthcare | 0.54% | ₹8.11 Cr | — | — | — |
| Gujarat Fluorochemicals Ltd. | Chemicals | 0.53% | ₹8.00 Cr | — | — | — |
| Others | Others | 0.28% | ₹4.11 Cr | +4.68% | +0.10% | +3.06% |
| Jubilant Pharmova Ltd. | Healthcare | 0.00% | ₹0.01 Cr | +0.91% | +0.34% | — |
Sectors
Instruments
Recent changes
| Holding | From | To | Weight |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | 0.12% | 3.76% | +3.64% |
| Mankind Pharma Ltd. | 2.91% | 0.77% | -2.14% |
| Glaxosmithkline Pharmaceuticals Ltd. | 2.72% | 0.76% | -1.96% |
| Global Health Ltd. | 1.68% | 0.00% | -1.68% |
| PI Industries Ltd. | 0.95% | 2.59% | +1.64% |
| Natco Pharma Ltd. | 0.00% | 1.51% | +1.51% |
| Fortis Healthcare Ltd. | 3.30% | 1.95% | -1.35% |
| Navin Fluorine International Ltd. | 0.00% | 1.18% | +1.18% |
| Metropolis Healthcare Ltd. | 1.11% | 0.00% | -1.11% |
| Prasol Chemicals Ltd. | 0.00% | 0.88% | +0.88% |
| Manipal Health Enterprises Ltd. | 1.24% | 0.59% | -0.65% |
| Gujarat Fluorochemicals Ltd. | 0.00% | 0.53% | +0.53% |
| Abbott India Ltd. | 5.44% | 5.94% | +0.50% |
| HDFC Life Insurance Co Ltd. | 0.50% | 0.00% | -0.50% |
| Acutaas Chemicals Ltd. | 1.48% | 1.95% | +0.47% |
| Dr. Reddy's Laboratories Ltd. | 4.21% | 4.65% | +0.44% |
| Sun Pharmaceutical Industries Ltd. | 8.43% | 7.99% | -0.44% |
| Anthem Biosciences Ltd. | 2.14% | 2.57% | +0.43% |
| Pfizer Ltd. | 2.92% | 2.50% | -0.42% |
| Healthcare Global Enterprises Ltd. | 6.30% | 5.92% | -0.38% |
| Molbio Diagnostics Ltd. | 0.87% | 0.54% | -0.33% |
| Biocon Ltd. | 0.99% | 0.69% | -0.30% |
| Jubilant Pharmova Ltd. | 0.25% | 0.00% | -0.25% |
| Procter & Gamble Health Ltd. | 2.51% | 2.75% | +0.24% |
| Symbiotec Pharmalab Ltd. | 0.64% | 0.87% | +0.23% |
| Others | 0.32% | 0.09% | -0.23% |
| Sumitomo Chemical India Ltd. | 1.59% | 1.38% | -0.21% |
| Sai Life Sciences Ltd. | 2.41% | 2.60% | +0.19% |
| Rainbow Children's Medicare Ltd. | 4.47% | 4.30% | -0.17% |
| Syngene International Ltd. | 3.02% | 2.85% | -0.17% |
| FDC Ltd. | 2.10% | 2.24% | +0.14% |
| Gillette India Ltd. | 1.09% | 1.23% | +0.14% |
| Lupin Ltd. | 3.26% | 3.14% | -0.12% |
| Dr. Lal Pathlabs Ltd. | 1.66% | 1.76% | +0.10% |
| Zim Laboratories Ltd. | 0.49% | 0.58% | +0.09% |
| Max Healthcare Institute Ltd. | 3.80% | 3.71% | -0.09% |
| Aster DM Quality Care Ltd. | 1.59% | 1.67% | +0.08% |
| Ajanta Pharma Ltd. | 1.57% | 1.63% | +0.06% |
| Sanofi Consumer Healthcare India Ltd. | 0.52% | 0.57% | +0.05% |
| Bayer CropScience Ltd. | 3.01% | 2.96% | -0.05% |
| Cipla Ltd. | 4.27% | 4.22% | -0.05% |
| Apollo Hospitals Enterprise Ltd. | 4.32% | 4.36% | +0.04% |
| Dr. Agarwal's Health Care Ltd. | 0.71% | 0.68% | -0.03% |
| Divi's Laboratories Ltd. | 5.65% | 5.68% | +0.03% |
| Ipca Laboratories Ltd. | 0.90% | 0.91% | +0.01% |
| Alkem Laboratories Ltd. | 2.35% | 2.36% | +0.01% |
Compare
Similar funds
The rest of the category, so this fund’s numbers have something to sit against.
| Fund | AUM | Expense | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| Category average | ₹2,892 Cr | 1.89% | 30.8% | 19.0% | 20.6% |
 SBI Healthcare Opportunities Fund | ₹5,870 Cr | 1.98% | 30.0% | 18.2% | 21.6% |
 HDFC Pharma And Healthcare Fund | ₹3,501 Cr | 2.11% | 34.0% | 24.0% | — |
 Mirae Asset Healthcare Fund | ₹3,494 Cr | 2.01% | 31.3% | 18.3% | 20.0% |
 UTI Healthcare Fund | ₹1,430 Cr | 2.21% | 26.3% | 17.0% | 20.2% |
 ICICI Prudential Nifty Pharma Index Fund | ₹163 Cr | 1.13% | 32.3% | 17.6% | — |
About
About this fund
The scheme’s own words, its benchmark and the people running it.
Investment objective
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
Fund managers
- Rajat SrivastavaMr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT GhaziabadPrior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services
Tools
Return calculator
What ₹10,000 a month in this fund would have grown to over each period, based on its past returns.
₹
| Over the past | Total investment | Would’ve become | Growth | Returns |
|---|---|---|---|---|
| 6 months5.26% absolute | ₹60,000 | ₹63,156 | 5.26% | |
| 1 year7.23% annualised | ₹1,20,000 | ₹1,24,805 | 4.00% | |
| 3 years17.42% annualised | ₹3,60,000 | ₹4,75,285 | 32.02% | |
| 5 years13.72% annualised | ₹6,00,000 | ₹8,65,212 | 44.20% |
Returns for 1 year and longer are annualised (CAGR); 6-month figures are absolute. Past returns are not a forecast.
How this is calculated
Each monthly instalment grows at the fund’s annualised return ÷ 12 per month until the end of the period, the same formula as our SIP calculator.
The amount compounds once a year at the fund’s CAGR for that period, the same formula as our lumpsum calculator.
Questions
Frequently asked questions
The things people ask about this scheme.
What is the NAV of Tata India Pharma & HealthCare Fund?
The NAV of Tata India Pharma & HealthCare Fund is ₹32.88 as on 6 Nov 2026.
What is the expense ratio of Tata India Pharma & HealthCare Fund?
The expense ratio of Tata India Pharma & HealthCare Fund is 2.41% per year.
What is the minimum SIP amount for Tata India Pharma & HealthCare Fund?
You can start a SIP in Tata India Pharma & HealthCare Fund with ₹3,000 a month.
What returns has Tata India Pharma & HealthCare Fund given?
Tata India Pharma & HealthCare Fund has returned 11.9% over 1 year, 9.5% over 3 years and 15.3% over 5 years (annualised).
Is there a lock-in or exit load on Tata India Pharma & HealthCare Fund?
Lock-in: None. Exit load: Exit load of 0.25% if redeemed within 30 days..
How risky is Tata India Pharma & HealthCare Fund?
Tata India Pharma & HealthCare Fund is rated Very High on the SEBI riskometer and belongs to the Sectoral-Pharma category.
Which fund house manages Tata India Pharma & HealthCare Fund?
Tata India Pharma & HealthCare Fund is managed by Tata Mutual Fund, which runs 62 schemes with ₹2,39,201 Cr under management.